casey orvin, president society for clinical research sites
TRANSCRIPT
Faculty DisclosureIn compliance with ACCME Guidelines, I hereby declare:
I do not have financial or other relationships with the manufacturer(s) of any commercial services(s) discussed in this educational activity.
Cheryl-Ann Hawkins, RN, MHA, Clinical Research Manager, Oncology, Alfred Health (Facilitator)
Tam Nguyen, FRSPH, FAIM, PhD, MBA, Deputy Director of Research, St. Vincent’s Hospital, Melbourne (Facilitator)
Carlos China, MD, Regional Clinical Site Lead, Pfizer
Gina Kennedy, MS, Senior Clinical Operations Manager, Covance
Marian Lieschke, RN, Manager, Parkville Cancer Clinical Trial Unit
Lorena Figueroa, B.Pharm, Country Clinical Operations Leader, Roche
Karen West, Executive Director, Clinical Development, Syneos Health
Kurt Lackovic, PhD, MBA, GAICD, CEO, Cancer Trials Australia
Disclaimer
Survey Supporters & Collaborators • CFS Clinical
• Clinical Leader
• DrugDev
• goBalto
• KMR Group
• Medidata
• Survey Respondents (that’s mostly all us sites!)
Any reference to companies is not an endorsement or statement of their services.
Check with your professional consultants (legal, financial, HR, etc.) to obtain specific information pertaining to your company.
This information is not meant to direct you on how to address any specific issues.
Antitrust–compliance policy adherence. http://myscrs.org/24-revision-v1/policies/antitrust-compliance-policy/
Summit Site Landscape Survey
4%
15%
44%
37%
Type of Site
Academic - 4%
Hospital - 15%
Practice - 44%
Freestanding - 37%
Years as a Site<4 – 10%
5-10 – 15%11-20 – 37%
21+ – 38%
SCRS Summit Survey 2018
How Does Your Site Compare?
Number of Staff
Percentage of Sites
SCRS Summit Survey 2018
0%
10%
20%
30%
40%
50%
1-3 4-6 7-9 +10
PIs CRCs Sub-Is
SCRS Summit Survey 2104, 2016, 2017, 2018
65%
66%
60%
64%
59%
61%
63%
65%
67%
2014 2016 2017 2018
Operating Cash
Less Than 3 Mos. Operating Cash
Withholding Trends
12% 13% 13%11% 12% 12% 12%
14% 11%
0%
4%
8%
12%
16%
20%
2006 2007 2008 2009 2013 2015 2016 2017 2018
Site Solutions Summit 2007, 2008, 2009 & 2010, 2013, 2016, 2017, 2018 CFS Clinical, DrugDev - 2015, *2016
Feeling the Partnership?
More of a Partner
Less of a Partner No Change
Sponsors 31% 23% 47%
CROs 22% 33% 46%
SCRS Summit Survey 2016
How Sites Feel Their Partnership Has Changed in the Last 2 Years
New Liaisons and Site Impact Opportunities• Site Identification Manager
• Vice President, SMO Affairs
• Director, Site & Patient Access
• Executive Director, Site and Patient Access
• Manager, Site and Patient Access
• Manager, Site Contracts
• Patient and Investigator Engagement
• Manager, Site Start-Up & Regulatory
• Associate Director, Site Management
• Site Solutions Director
• Vice President, Site and Patient Access
• Associate Director, Site Intelligence
• Vice President, Site Intelligence & Strategic Development
• Head of Site Relationship Management
• Director, Site Intelligence and Activation
• Director, Site Technologies
• Investigator Site Development Lead
• Senior Director, Site Intelligence, Site Centricity Unit Clinical Division
• Vice President, Site Intelligence & Strategic Development
• Associate Director, Site Management
• Senior Director, Site Alliances
• Head of Site and Patient Networks for NA
• Senior Director Site and Patient Networks
• Vice President, Head Site and Patient Networks, Americas
• AND MORE
Communication – The Sites’ View
• One point of contact!
• Improve senior site management engagement on issues.
• More communication. Feels like the site is always reaching out to get
info but the Sponsor/CRO is never there.
• Abide more closely to agreed payment terms.
• Build and MAINTAIN relationships with sites.
• Maintain a communication log so we can see how long it takes
Sponsors/CROs to respond.
• Timely response for questions & queries.
Communication – The Sponsor/CROs’ View
• One or two persons should be main contact.
• Sites should be more proactive when they are unsure about what to do.
• Prompt reply on the CRA/DM queries.
• Not sending out emails for every issue.
• Timely return of phone calls and e-mails.
• Partnership to improve communication both ways!
SCRS Pain Point Survey 17
Number of Contacts at the Sponsor or CRO Per Protocol - Comparing This Year to Last
Increased 44%
Stayed the Same44%
Decreased 12%
SCRS Summit Survey 2018
Communication With Sites On Protocol Related Issues – Comparing this year to last
0%
20%
40%
60%
Improved
Stayed the Same
Worsened
19%
66%
15%
17%
56%
27%
Sponsor CRO
SCRS Summit Survey 2018
Are you able to quickly reach a knowledgeable person to get an answer to a protocol-related question?
0% 10% 20% 30% 40% 50%
Always
Often
Sometimes
Rarely
Never
CRO Sponsor SCRS Summit Survey 2018
68% Reported Direct Contact With
Decision Maker To Be Extremely Beneficial
Tam Nguyen, FRSPH, FAIM, PhD, MBA, Deputy Director of Research, St. Vincent’s Hospital, Melbourne (Facilitator)
Lorena Figueroa, B.Pharm, Country Clinical Operations Leader, Roche
Karen West, Executive Director, Clinical Development, Syneos Health
Kurt Lackovic, PhD, MBA, GAICD, CEO, Cancer Trials Australia
Site Partnerships and Communication
Site Activation Investment ~14 Mos.
Clinical Leader May 2016
3.2 Mos. 8 Mos. 2.5 Mos.
Site Selection Pre-Visit - Contract Executed Site Initiation - Activation
Comparison to Oncology in Victoria
Clinical Leader May 2016
3.2 Mos. 8 Mos. 2.5 Mos.
Site Selection Pre-Visit - Contract Executed Site Initiation - Activation
3 Mos. 3.1 Mos.
Site Selection HREC Submission to SIV
Data is presented as medians from over 100 Cancer Trials Australia supported oncology studies, across multiple Victorian hospitals in 2018, total calendar days, no ‘stop clocks’ applied.
Time to Execute Contracts Globally
10.92
9.91
17.23
12.72
15.38
0 2 4 6 8 10 12 14 16 18 20
Contract
Asia Pac EMEA LA NA Global
*10.3 weeksgoBalto 2016, *KMR Group 2016
Site’s Solutions to Enhance Study Start-Up1. Provide more study information during feasibility process
2. Provide financial information during the feasibility process
3. Less time between when site is approved to begin study and site initiation
4. Streamline budget process
5. Standardize contract clauses
6. One system to enter dataSCRS Summit Survey 2016
Not selected for a study?
How often do youhear back about the decision?
Always8%
Often27%
Sometimes31%
Seldom29%
Never5%
SCRS Summit Survey 2018
Site Qualification Visits
Always 4%
Often 36%
Sometimes 41%
Rarely 18%
Never 2%Do the CRAs have adequate knowledge about the study?
SCRS Summit Survey 2018
Site Qualification Visits
How does the study knowledge of the CRA compare to last year?
SCRS Summit Survey 2018
8%
63%
29%
Improved
Same
Worsened
Did I Answer Your Questions?
How often does the CRA follow up with answers to questions raised at the SQV?
SCRS Summit Survey 2018Always - 11%
Often - 47%
Sometimes - 33%
Rarely - 8%
Never - 1%
0%
10%
20%
30%
40%
50%
Of all the clinical trial agreements you signed, indicate the most frequent payment terms:
49%
28%
16%
44%39%
10%
Quarterly Monthly Bi-monthly
2016 2017SCRS Summit Survey 2018
What is your preferred payment schedule?77%
10%6% 6%
Monthly I have nopreference
Bi-monthly Quarterly SCRS Summit Survey 2018
When negotiating a quarterly or bi-monthly payment schedule to a monthly payment schedule:
60%
13%
2%
13% 12%
6%
32%
25%28%
9%
Every time Most of the time Half of the time Some of the time Never
How often do you try to negotiate better terms?
How successful are you?
SCRS Summit Survey 2018
Cheryl-Ann Hawkins, RN, MHA, Clinical Research Manager, Oncology, Alfred Health (Facilitator)
Carlos China, MD, Regional Clinical Site Lead, Pfizer
Gina Kennedy, MS, Senior Clinical Operations Manager, Covance
Marian Lieschke, RN, Manager, Parkville Cancer Clinical Trial Unit
Study Startup, Feasibility, and Finance
Site Landscape SurveyEnsure the Asia-Pac Site Voice is Heard
MySCRS.org/Learning-Campus/Surveys